21 Feb, EOD - Indian

SENSEX 75311.06 (-0.56)

Nifty 50 22795.9 (-0.51)

Nifty Bank 48981.2 (-0.72)

Nifty IT 40544.5 (-0.79)

Nifty Midcap 100 50486.2 (-1.32)

Nifty Next 50 60466.8 (-0.94)

Nifty Pharma 20385.65 (-1.92)

Nifty Smallcap 100 15636.9 (-0.70)

21 Feb, EOD - Global

NIKKEI 225 38776.94 (0.26)

HANG SENG 23477.92 (3.99)

S&P 6041.75 (-1.74)

Login/Signup
LOGIN HERE
Cancel

companylogoSun Pharma Advanced Research Company Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 532872 | NSE Symbol : SPARC | ISIN : INE232I01014 | Industry : Miscellaneous |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
31-Jan-2025 10-Feb-2025 Quarterly Results SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve financial results for the quarter and nine months ended December 31 2024 Financial Results for the quarter and nine months ended December 31, 2024 (As Per Bse Announcement Dated on 10.02.2025)
25-Oct-2024 04-Nov-2024 Quarterly Results SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2024 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended September 30 2024. Outcome of Board Meeting for Unaudited Financial Results for the Quarter and Half year ended September 30, 2024 (As Per BSE Announcement dated on 04.11.2024) Clarification - Financial Results for the quarter and half year ended September 30, 2024 (As Per BSE Announcement Dated on 05.11.2024)
29-Jul-2024 05-Aug-2024 Quarterly Results SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve the Standalone and Consolidated Financial Results of the Company for the first quarter ended June 30 2024 Outcome of Board Meeting for Unaudited Financial Results for the quarter ended June 30, 2024 Financial Results for the quarter ended June 30 2024 (As per BSE Announcement Dated on 05/08/2024)
15-Jul-2024 15-Jul-2024 Change in Directors Disclosure under Regulation 30 of LODR regarding appointment of Ms. Vidhi Shanghvi as an Additional Non-Executive, Non-Independent Director
17-May-2024 24-May-2024 Accounts SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve As attached Outcome of Board Meeting (As Per BSE Announcement dated on 24.05.2024)
24-Jan-2024 05-Feb-2024 Quarterly Results SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve The Unaudited financial results of the company for the quarter and nine months ended December 31 2023. As attached (As Per BSE Announcement Dated on: 05/02/2024)
27-Oct-2023 06-Nov-2023 Quarterly Results SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Board Meeting Intimation Financial Results for the quarter and half year ended September 30, 2023 (As per BSE Announcement Dated on 06/11/2023)
29-Jul-2023 07-Aug-2023 Quarterly Results SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 inter alia to consider and approve the Unaudited Financial Results for the quarter ended June 30 2023 As per the attachment (As Per BSE Announcement Dated on 07.08.2023)
15-May-2023 22-May-2023 Accounts SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2023 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31 2023 Audited Financial Results for the quarter and year ended March 31, 2023 The Board of Directors of the Company at its meeting held today i.e. May 22, 2023, inter alia, have 1. considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2023. 2. considered and approved for seeking approval from the shareholders of the Company by passing an enabling special resolution at the ensuing Annual General Meeting for Fund Raising (As Per BSE Announcement dated on 22.05.2023)
04-Feb-2023 13-Feb-2023 Quarterly Results SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and Nine Months ended December 31, 2022 Outcome of the Board Meeting held today i.e. February 13, 2023 (As Per BSE Announcement Dated on 13/02/2023)
28-Oct-2022 07-Nov-2022 Quarterly Results SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2022 Outcome of the Board Meeting held today i.e. November 07 2022 (As Per BSE Announcement Dated on 07.11.2022)
01-Aug-2022 08-Aug-2022 Quarterly Results Quarterly Results & Inter alia, to consider and evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. As attached. (As Per BSE Announcement Dated on 08/08/2022)
09-May-2022 17-May-2022 Accounts SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2022 inter alia to consider and approve Audited Financial Results of the Company for the quarter and financial year ended March 31 2022. As per letter attached (As Per BSE Announcement Dated on 17.05.2022)
27-Jan-2022 04-Feb-2022 Quarterly Results SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2021. As per letter attached (As Per BSE Announcement Dated on 04.02.2022)
25-Oct-2021 01-Nov-2021 Quarterly Results Quarterly Results As per Letter attached (As per BSE Announcement Dated on 01/11/2021)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +